Division of Hematology/Oncology


faculty photo

Stephen J. Schuster, M.D.

Robert and Margarita Louis-Dreyfus Associate Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Attending Physician, Department of Medicine, Division of Hematology-Oncology, Hospital of the University of Pennsylvania
Director, Lymphoma Translational Research, Abramson Cancer Center of the University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
2 South Pavilion, Room 2-393S
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 614-1846
Fax: (215) 662-4064
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.

Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
Jefferson Medical College, Philadelphia, PA, 1981.
Post-Graduate Training
Medical Internship, Pennsylvania Hospital, Philadelphia, PA., 1981-1982.
Resident in Medicine, Pennsylvania Hospital, Philadelphia, PA, 1982-1984.
Cardeza Clinical and Research Fellow in Medicine (Hematology), Jefferson Medical College, Philadelphia, PA, 1984-1988.
Postdoctoral Research Fellowship (NIH Sponsored Individual NRSA), Cardeza Foundation for Hematologic Research, Jefferson Medical College, Philadelphia, PA, 1986-1988.
Medical Oncology Fellowship, Pennsylvania Hospital, Philadelphia, PA, 1988-1989.
Diplomate, National Board of Medical Examiners, 1982.
Diplomate, American Board of Internal Medicine, 1984.
Diplomate, American Board of Hematology, 1986.
Diplomate, American Board of Medical Oncology, 1989.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Ruan, Jia. Martin, Peter. Shah, Bijal. Schuster, Stephen J. Smith, Sonali M. Furman, Richard R. Christos, Paul. Rodriguez, Amelyn. Svoboda, Jakub. Lewis, Jessica. Katz, Orel. Coleman, Morton. Leonard, John P.: Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma. The New England Journal of Medicine. 373(18): 1835-44, Nov 5 2015.

Luskin, Marlise R. Heil, DS. Tan, KS. Choi, Sarah. Stadtmauer, Edward A. Schuster, Stephen J. Porter, David L. Vonderheide, Robert H. Bagg, Adam. Heitjan, Daniel F. Tsai, Donald E. Reshef, Ran.: The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American Joural of Transplant. 15(10): 2665-73, Oct 2015 Notes: [Epub ahead of print]May 18, 2015.

Paul, Thomas M. Liu, Stephen V. Chong, Elise A. Luger, Selina M. Porter, David L. Schuster, Stephen J. Tsai, Donald E. Nasta, Sunita D. Loren, Alison. Frey, Noelle. Perl, Alexander. Cohen, Adam D. Weiss, Brendan M. Stadtmauer, Edward A. Vogl, Dan T.: Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clinical Lymphoma Myeloma and Leukemia. 15(9): 536-40, Sep 2015.

Huntington, Scott F. Nasta, Sunita D. Schuster, Stephen J. Doshi, Jalpa A. Svoboda, Jakub. : Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma. 56(9): 2579-84, Sep 2015.

Howlett, Christina. Snedecor, Sonya J. Landsburg, Daniel J. Svoboda, Jakub. Chong, Elis A. Schuster, Stephen J. Nasta, Sunita D. Feldman, Tatyana. Rago, Allison. Walsh, Kristy M. Weber, Scott. Goy, Andre. Mato, Anthony.: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology. 170(4): 504-14, Aug 2015.

Mato, Anthony R. Foon, Kenneth A. Feldman, Tatyana. Schuster, Stephen J. Svoboda, Jakub. Chow, Kar Fai. Valentinetti, Marisa. Mrkulic, Mary. Azzollini, Kelly. Gadaleta, Gabriella. Bhattacharyya, Pritish K. Zenreich, Joshua. Pascual, Lauren-Nicole. Yannotti, Kara. Kdiry, Sabrina. Howlett, Christina. Strelec, Lauren. Porter, David. Bejot, Coleen. Goy, André.: Reduced-dose fludarabine, cyclophosphamide and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology. 90(6): 487-92, Jun 2015.

Chong, Elise A. Ahmadi, Tahamtan. Aqui, Nicole A. Svoboda, Jakub. Nasta, Sunita D. Mato, Anthony R. Walsh, Kristy M. Schuster, Stephen J.: Combination of lenalidomide and rituximab overcomes rituximab-resistance in patients with indolent B-cell and mantle cell lymphomas. Clinical Cancer Research. 21(8): 1835-42, Apr 15 2015.

Wagner, Lynne I. Zhao, Fengmin. Hong, Fangxin. Williams, Michael E. Gascoyne, Randy D. Krauss, John C. Advani, Ranjana H. Go, Ronald S. Habermann, Thomas M. Leach, Joseph W. O'Connor, Brian. Schuster, Stephen J. Cella, David. Horning, Sandra J. Kahl, Brad S.: Anxiety and Health-Related Quality of Life Among Patients With Low–Tumor Burden Non-Hodgkin Lymphoma Randomly Assigned to Two Different Rituximab Dosing Regimens: Results From ECOG Trial E4402 (RESORT). Journal of Clinical Oncology. 33(7): 740-8, Mar 1 2015.

Frosch, Zachary. Luskin, Marlise R. Landsburg, Daniel J. Schuster, Stephen J. Svoboda, Jakub. Loren, Alison W. Porter, David L. Stadtmauer, Edward A. Nasta, Sunita D.: R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia. 15(2), Feb 2015.

Nagle, Sarah J. Chong, Elise A. Chekol, Seble. Shah, Nirav N. Nasta, Sunita D. Glatstein, Eli. Plastaras, John P. Torigian, Drew A. Schuster, Stephen J. Svoboda, Jakub.: The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. Cancer Medicine. 4(1): 7-15, Jan 4 2015.

back to top
Last updated: 11/23/2015
The Trustees of the University of Pennsylvania

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter